Pharmacist's perspective on HCQ treatment of COVID-19
- PMID: 32533592
- PMCID: PMC7323069
- DOI: 10.1002/kjm2.12249
Pharmacist's perspective on HCQ treatment of COVID-19
Conflict of interest statement
All authors declare no conflict of interest.
Comment on
-
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20. Int J Antimicrob Agents. 2020. Retraction in: Int J Antimicrob Agents. 2025 Jan;65(1):107416. doi: 10.1016/j.ijantimicag.2024.107416. PMID: 32205204 Free PMC article. Retracted. Clinical Trial.
References
-
- McChesney EW, Banks WF Jr, Fabian RJ. Tissue distribution of chloroquine, hydroxychloroquine, and desethylchloroquine in the rat. Toxicol Appl Pharmacol. 1967;10:501–513. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources